Search research articles
Contact Us
Filters
Showing results (61-70 of 361) with videos related to
Page
of 37
Sort By:
The American Journal of Medicine
|
June 24, 2018
The Reply
Larry A Weinrauch, John A D'Elia, Matthew R Weir, et al.
European Journal of Heart Failure
|
October 29, 2025
Efficacy and safety of vutrisiran in transthyretin amyloid cardiomyopathy across the age spectrum: The HELIOS-B trial
Awais Sheikh, Zi Michael Miao, Brian Claggett, et al.
The American Journal of Medicine
|
September 26, 2017
Infection and Malignancy Outweigh Cardiovascular Mortality in Kidney Transplant Recipients: Post Hoc Analysis of the FAVORIT Trial
Larry A Weinrauch, John A D'Elia, Matthew R Weir, et al.
Journal of the American College of Cardiology
|
November 29, 2023
Changes in Pulmonary Artery Pressure Late in Life: The Atherosclerosis Risk in Communities (ARIC) Study
Rani Zierath, Brian Claggett, Victoria Arthur, et al.
International Journal of Cardiology
|
April 22, 2021
Combining diastolic dysfunction and natriuretic peptides to risk stratify patients with heart failure with reduced ejection fraction
Mauro Gori, Brian Claggett, Michele Senni, et al.
Digestive Diseases and Sciences
|
April 22, 2016
Epithelial Cell Extrusion Zones Observed on Confocal Laser Endomicroscopy Correlates with Immunohistochemical Staining of Mucosal Biopsy Samples
Julia J Liu, Theresa M Kay, Elisabeth M Davis, et al.
Journal of the American Heart Association
|
November 2, 2017
Prognostic Value of Cardiopulmonary Exercise Testing in Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction
Wilson Nadruz, Erin West, Morten Sengeløv, et al.
European Heart Journal
|
April 14, 2016
Cardiac structure and function and leisure-time physical activity in the elderly: The Atherosclerosis Risk in Communities Study
Sheila M Hegde, Alexandra Gonçalves, Brian Claggett, et al.
JAMA Oncology
|
October 5, 2017
Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio
Kyongsun Pak, Hajime Uno, Dae Hyun Kim, et al.
JACC. Heart Failure
|
March 5, 2018
Natriuretic Peptides as Biomarkers of Treatment Response in Clinical Trials of Heart Failure
Muthiah Vaduganathan, Brian Claggett, Milton Packer, et al.
Page
of 37
Search research articles
Search
Showing results (61-70 of 361) with videos related to
Sort By:
Page
of 37
The American Journal of Medicine
|
June 24, 2018
The Reply
Larry A Weinrauch, John A D'Elia, Matthew R Weir, et al.
European Journal of Heart Failure
|
October 29, 2025
Efficacy and safety of vutrisiran in transthyretin amyloid cardiomyopathy across the age spectrum: The HELIOS-B trial
Awais Sheikh, Zi Michael Miao, Brian Claggett, et al.
The American Journal of Medicine
|
September 26, 2017
Infection and Malignancy Outweigh Cardiovascular Mortality in Kidney Transplant Recipients: Post Hoc Analysis of the FAVORIT Trial
Larry A Weinrauch, John A D'Elia, Matthew R Weir, et al.
Journal of the American College of Cardiology
|
November 29, 2023
Changes in Pulmonary Artery Pressure Late in Life: The Atherosclerosis Risk in Communities (ARIC) Study
Rani Zierath, Brian Claggett, Victoria Arthur, et al.
International Journal of Cardiology
|
April 22, 2021
Combining diastolic dysfunction and natriuretic peptides to risk stratify patients with heart failure with reduced ejection fraction
Mauro Gori, Brian Claggett, Michele Senni, et al.
Digestive Diseases and Sciences
|
April 22, 2016
Epithelial Cell Extrusion Zones Observed on Confocal Laser Endomicroscopy Correlates with Immunohistochemical Staining of Mucosal Biopsy Samples
Julia J Liu, Theresa M Kay, Elisabeth M Davis, et al.
Journal of the American Heart Association
|
November 2, 2017
Prognostic Value of Cardiopulmonary Exercise Testing in Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction
Wilson Nadruz, Erin West, Morten Sengeløv, et al.
European Heart Journal
|
April 14, 2016
Cardiac structure and function and leisure-time physical activity in the elderly: The Atherosclerosis Risk in Communities Study
Sheila M Hegde, Alexandra Gonçalves, Brian Claggett, et al.
JAMA Oncology
|
October 5, 2017
Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio
Kyongsun Pak, Hajime Uno, Dae Hyun Kim, et al.
JACC. Heart Failure
|
March 5, 2018
Natriuretic Peptides as Biomarkers of Treatment Response in Clinical Trials of Heart Failure
Muthiah Vaduganathan, Brian Claggett, Milton Packer, et al.
Page
of 37